BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16615136)

  • 1. Fluence rate as a modulator of PDT mechanisms.
    Henderson BW; Busch TM; Snyder JW
    Lasers Surg Med; 2006 Jun; 38(5):489-93. PubMed ID: 16615136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.
    Penjweini R; Kim MM; Liu B; Zhu TC
    J Biophotonics; 2016 Dec; 9(11-12):1344-1354. PubMed ID: 27653233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.
    Wang KK; Finlay JC; Busch TM; Hahn SM; Zhu TC
    J Biophotonics; 2010 Jun; 3(5-6):304-18. PubMed ID: 20222102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light Fluence Rate and Tissue Oxygenation (S
    Dupre PJ; Ong YH; Friedberg J; Singhal S; Carter S; Simone CB; Finlay JC; Zhu TC; Cengel KA; Busch TM
    Photochem Photobiol; 2020 Mar; 96(2):417-425. PubMed ID: 32048732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species explicit dosimetry to predict local tumor control for Photofrin-mediated photodynamic therapy.
    Sheng T; Ong YH; Busch TM; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2019 Feb; 10860():. PubMed ID: 31327886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel investigational preclinical model to assess fluence rate for dental oral craniofacial tissues.
    Sourvanos D; Zhu TC; Dimofte A; Busch TM; Lander B; Burrell JC; Neiva R; Fiorellini JP
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104015. PubMed ID: 38373469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-Vivo Optical Monitoring of the Efficacy of Epidermal Growth Factor Receptor Targeted Photodynamic Therapy: The Effect of Fluence Rate.
    Peng W; de Bruijn HS; Ten Hagen TLM; Berg K; Roodenburg JLN; van Dam GM; Witjes MJH; Robinson DJ
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31940973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated light dosimetry system for prostate photodynamic therapy.
    Li J; Zhu TC; Zhou X; Andreea D; Finlay JC
    Proc SPIE Int Soc Opt Eng; 2008 Jan; 6845():. PubMed ID: 26113761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of PDT parameters for RIF and H460 tumor models during HPPH-mediated PDT.
    Liu B; Kim MM; Gallagher-Colombo SM; Busch TM; Zhu TC
    Proc SPIE Int Soc Opt Eng; 2014 Mar; 8931():. PubMed ID: 25999649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlocking the Power of Light on the Skin: A Comprehensive Review on Photobiomodulation.
    Hernández-Bule ML; Naharro-Rodríguez J; Bacci S; Fernández-Guarino M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant Enzymes in Cancer Cells: Their Role in Photodynamic Therapy Resistance and Potential as Targets for Improved Treatment Outcomes.
    Udomsak W; Kucinska M; Pospieszna J; Dams-Kozlowska H; Chatuphonprasert W; Murias M
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic Therapy-Induced Anti-Tumor Immunity: Influence Factors and Synergistic Enhancement Strategies.
    Chou W; Sun T; Peng N; Wang Z; Chen D; Qiu H; Zhao H
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The upregulation of immune checkpoints after photodynamic therapy reducing immune effect for treating breast cancer.
    Long S; Wang B; Cui Y; Shao J; Zhao Y; Xu Y; Li H; Qiu H; Zhao H; Zeng J; Chen D; Li X; Gu Y
    Lasers Med Sci; 2023 Oct; 38(1):243. PubMed ID: 37882915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Light Source Technologies for Photodynamic Therapy of Skin Cancer Lesions.
    Algorri JF; López-Higuera JM; Rodríguez-Cobo L; Cobo A
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic Photodynamic Therapy with Conjugated Polymer Nanoparticles in Glioblastoma Tumor Microenvironment.
    Caverzán MD; Oliveda PM; Beaugé L; Palacios RE; Chesta CA; Ibarra LE
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Optimization of Irradiance and Fluence for Interstitial Photodynamic Therapy Treatment of Patients with Malignant Central Airway Obstruction.
    Oakley E; Parilov E; Beeson K; Potasek M; Ivanick N; Tworek L; Hutson A; Shafirstein G
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Challenges and Opportunities of Photodynamic Therapy against Cancer.
    Huis In 't Veld RV; Heuts J; Ma S; Cruz LJ; Ossendorp FA; Jager MJ
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photothermally Controlled Drug Release of Poly(d,l-lactide) Nanofibers Loaded with Indocyanine Green and Curcumin for Efficient Antimicrobial Photodynamic Therapy.
    Gutberlet B; Preis E; Roschenko V; Bakowsky U
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermoresponsive Liposomes for Photo-Triggered Release of Hypericin Cyclodextrin Inclusion Complex for Efficient Antimicrobial Photodynamic Therapy.
    Dayyih AA; Gutberlet B; Preis E; Engelhardt KH; Amin MU; Abdelsalam AM; Bonsu M; Bakowsky U
    ACS Appl Mater Interfaces; 2022 Jul; 14(28):31525-31540. PubMed ID: 35790214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parietin Cyclodextrin-Inclusion Complex as an Effective Formulation for Bacterial Photoinactivation.
    Ayoub AM; Gutberlet B; Preis E; Abdelsalam AM; Abu Dayyih A; Abdelkader A; Balash A; Schäfer J; Bakowsky U
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.